본문 바로가기
KERD
논문KCI 등재

위식도역류질환 한약제제 임상시험 가이드라인 개발을 위한 관련 국내 가이드라인 분석 및 기존 한약임상시험과의 비교

An Analysis of the Existing Guidelines and Clinical Trials for the Development of the Guidelines of Clinical Trials with Herbal Medicinal Products for Gastroesophageal Reflux Disease (GERD)

이준희|한가진|임정태|김진성
대한한방내과학회 (The Society Of Korean Oriental Internal Medicine)|2016.03|대한한방내과학회지 (The Journal of Korean Oriental Internal Medicine)|제37권 제1호|pp. 90-108

1

조회

0

다운로드

3

인용

0

참고문헌

키워드

clinical trialguidelinegastroesophageal reflux disease (GERD)herbal medicinal products
주제분류한의학

초록

Objectives: This study aimed to learn what should be considered in the Guidelines of Clinical Trials with Herbal Medicinal Products for Gastroesophageal Reflux Disease (GERD) by analyzing the existing guidelines and clinical trials. Methods: The development committee searched the existing guidelines for herbal medicinal products or GERD. Then, clinical trials related to GERD using herbal medicine were selected. The chosen trials were analyzed in terms of their inclusion and exclusion of participants, intervention, comparators, outcome, and trial design. Then, we compared the results of the analysis according to the regulations and guidelines of the Ministry of Food and Drug Safety to suggest the issues that we will have to consider when developing the Guidelines of Clinical Trials with Herbal Medicinal Products for Gastroesophageal Reflux Disease (GERD). Results: As a result, few guidelines for GERD and clinical trials with herbal medicinal products were located in the national institution homepage. In addition, 8 articles were found using the following combination of search terms: “Gastroesophageal reflux disease”, “GERD”, “herbal medicine”, “herbal therapy”, “Korean Medicine”, “Traditional Chinese Medicine”, and “TCM”. Even though all trials had their own unique research questions, all studies were performed using a randomization method. Most trials included participants with reflux esophagitis, but two trials targeted proton pump inhibitor-refractory GERD. The type of intervention varied, such as decoction, granules, and capsules. Additionally, individualized herbal medicines were used in two studies. Comparators were diverse, such as placebo, Western medicine, and electro-acupuncture. The most frequently used outcome for efficacy was the effectiveness rate. In addition, the outcome for evaluating quality of life, esophageal mucosa and pressure, esophageal acid reflux, and recurrence rates were used. Safety was investigated by recording adverse events and carrying out laboratory tests. Conclusions: We identified some issues by reviewing the existing guidelines and comparing them with clinical trials for GERD and herbal medicinal products. These results will be utilized for developing the Guidelines of Clinical Trials with Herbal Medicinal Products for Gastroesophageal Reflux Disease (GERD).

Abstract

Objectives: This study aimed to learn what should be considered in the Guidelines of Clinical Trials with Herbal Medicinal Products for Gastroesophageal Reflux Disease (GERD) by analyzing the existing guidelines and clinical trials. Methods: The development committee searched the existing guidelines for herbal medicinal products or GERD. Then, clinical trials related to GERD using herbal medicine were selected. The chosen trials were analyzed in terms of their inclusion and exclusion of participants, intervention, comparators, outcome, and trial design. Then, we compared the results of the analysis according to the regulations and guidelines of the Ministry of Food and Drug Safety to suggest the issues that we will have to consider when developing the Guidelines of Clinical Trials with Herbal Medicinal Products for Gastroesophageal Reflux Disease (GERD). Results: As a result, few guidelines for GERD and clinical trials with herbal medicinal products were located in the national institution homepage. In addition, 8 articles were found using the following combination of search terms: “Gastroesophageal reflux disease”, “GERD”, “herbal medicine”, “herbal therapy”, “Korean Medicine”, “Traditional Chinese Medicine”, and “TCM”. Even though all trials had their own unique research questions, all studies were performed using a randomization method. Most trials included participants with reflux esophagitis, but two trials targeted proton pump inhibitor-refractory GERD. The type of intervention varied, such as decoction, granules, and capsules. Additionally, individualized herbal medicines were used in two studies. Comparators were diverse, such as placebo, Western medicine, and electro-acupuncture. The most frequently used outcome for efficacy was the effectiveness rate. In addition, the outcome for evaluating quality of life, esophageal mucosa and pressure, esophageal acid reflux, and recurrence rates were used. Safety was investigated by recording adverse events and carrying out laboratory tests. Conclusions: We identified some issues by reviewing the existing guidelines and comparing them with clinical trials for GERD and herbal medicinal products. These results will be utilized for developing the Guidelines of Clinical Trials with Herbal Medicinal Products for Gastroesophageal Reflux Disease (GERD).

참고문헌 (38)

  1. 김지현, "위식도역류질환의 최근 동향", 대한소화기학회지, 64(3), pp.127~132 (2014), 대한소화기학회
  2. Cho YS, "Prevalence and clinical spectrum of gastroesophageal reflux:a population-based study in Asan-si, Korea", Am J Gastroenterol, 100(4), pp.747~753 (2005)
  3. 정혜경, "위식도역류질환 임상진료지침 개정안 2012", 대한소화기학회지, 60(4), pp.195~218 (2012), 대한소화기학회
  4. 이준행, "위식도역류질환의 치료에 관한 임상진료지침", 대한소화기학회지, 57(2), pp.57~66 (2011), 대한소화기학회
  5. Donnellan C, "Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease", Cochrane Database Syst Rev, pp.CD003245~ (2005)
  6. Fass R, "Refractory GERD:what is it?", Curr Gastroenterol Rep, 10(3), pp.252~257 (2008)
  7. Hayden C, "Usage of supplemental alternative medicine by community-based patients with gastroesophageal reflux disease (GERD)", Dig Dis Sci, 47(1), pp.1~8 (2002)
  8. Committee on the publishing text of Korean Internal Medicine on Spleen, "Internal Medicine on Spleen", pp.314~318 (2009), Koonja Publishing Inc
  9. 한가진, "위식도역류질환 변증도구 개발 연구", 대한한방내과학회지, 36(2), pp.122~152 (2015), 대한한방내과학회
  10. 한국보건산업진흥원, "국내의약품임상시험현황 및전망", pp.7~14 (2006), 한국보건산업진흥원
  11. 이재은, "식도열공탈장을 동반한 위식도 역류성 질환 환자 치험 1례", 대한한방내과학회지, 26(1), pp.1~17 (2005), 대한한방내과학회
  12. 김윤희, "熱多寒少湯으로 호전된 역류성 식도염 환자 1례", 사상체질의학회지, 23(1), pp.132~138 (2011), 사상체질의학회
  13. 식품의약품안전처 식품의약품안전평가원 의약품심사부 소화계약품과, "위식도역류질환 치료제의 임상시험평가 가이드라인", 식품의약품안전처, ~ (2014)
  14. 정희, "성요한초제제 임상시험 고찰을 통한 한약기원 항우울제 임상시험 방법론 연구", 대한한방내과학회지, 28(2), pp.365~378 (2007), 대한한방내과학회
  15. 식품의약품안전청 생약평가부, "생약(한약)제제임상시험의 일반적 고려사항", 식품의약품안전청, ~ (2007)
  16. 한국한의학연구원, "천연물신약⋅한약제제임상시험가이드라인 연구" (2004), 식품의약품안전청
  17. 경희대학교산학협력단, "한약제제의 임상시험평가지표개발에 관한 연구" (2006), 식품의약품안전청
  18. Tominaga K, "Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan", J Gastroenterol, 47(3), pp.284~292 (2012)
  19. Tominaga K, "A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor:the G-PRIDE study", J Gastroenterol, 49(10), pp.1392~1405 (2014)
  20. Ghen JY, "Clinical observation on treatment of gastro-esophageal reflux with modified zhizhu pill", Zhongguo Zhong Xi Yi Jie He Za Zhi, 24(1), pp.25~27 (2004)
  21. Zhang Q, "Clinical effects of dalitong granule combined proton pump inhibitors on gastroesophageal reflux disease", Zhongguo Zhong Xi Yi Jie He Za Zhi, 32(4), pp.464~467 (2012)
  22. Xu HR, "Study on integrated Chinese and Western therapy and criterion for efficacy evaluation of gastroesophageal reflux disease-a clinical observation on 116 cases", Zhongguo Zhong Xi Yi Jie He Za Zhi, 27(3), pp.204~207 (2007)
  23. Zhai XH, "Clinical observation on treatment of reflux gastro-esophagitis by syndromedifferentiation depending therapy of TCM", Zhongguo Zhong Xi Yi Jie He Za Zhi, 24(11), pp.1014~1015 (2004)
  24. Zhang C, "Clinical curative effect of electroacupuncture combined with Zhizhukuanzhong Capsules for treating gastroesophageal reflux disease", J Tradit Chin Med, 32(3), pp.364~371 (2012)
  25. Zhang CX, "Clinical efficacy of electroacupuncture combined with dalitong granule for gastroesophageal reflux disease and its mechanism", Zhongguo Zhen Jiu, 32(6), pp.491~498 (2012)
  26. Kusano M, "Development and evaluation of FSSG; frequency scale for the symptoms of GERD", J Gastroenterol, 39, pp.888~891 (2004)
  27. Fass R, "Symptom assessment tools for gastroesophageal reflux disease (GERD) treatment", J Clin Gastroemterol, 41, pp.437~444 (2007)
  28. Johnson LF, "Development of 24-hour pH monitoring of the distal esophagus", Am J Gastrenterol, 6, pp.325~330 (1974)
  29. Savary M, "The Esophagus. Handbook and Atlas of Endoscopy" (1978), Gassmann Verlag
  30. Lundell LR, "Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification", Gut, 45, pp.172~180 (1999)
  31. Chinese Society of Gastrointestinal Endoscopy, "Crietrion of di-agnosis and treatment for gastroesophageal reflux disease／reflux esophagitis (trial", Chin J Gastroenterol, 5(4), pp.25~ (2000)
  32. 陆再英, "内科学", pp.372~375 (2008), 人民卫生出版社
  33. Hu J, "Psychometric properties of the Chinese version of the SF-36in older adults with diabetes in Beijing, China", Diabetes Res Clin Pract, 88(3), pp.273~281 (2010)
  34. DeVault KR, "Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease", Am J Gastroenterol, 100, pp.190~200 (2005)
  35. 김나영, "위식도역류질환 update", 제9회 분당서울대학교병원 내과 연수강좌, 85~93 (2012)
  36. Irvine EJ, "Design of treatment trials for functional gastrointestinal disorders", Gastroenterology, 130(5), pp.1538~1551 (2006)
  37. Vakil NB, "Systematic review of patient-reported outcome instruments for gastroesophageal reflux disease symptoms", Eur J Gastroenterol Hepatol, 25(1), pp.2~14 (2013)
  38. Mouli VP, "Questionnaire based gastroesophageal reflux disease (GERD) assessment scales", Indian J Gastroenterol, 30(3), pp.108~117 (2011)

이 간행물의 다른 논문 (9건)

한방병원에 입원한 도심지와 농촌지역 중풍 환자 비교 연구고호연, 공경환, 성현경, 이주아, 최지애, 김영지, 하예진, 고승우pp. 1-7비글견을 이용한 GST 추출물의 단회 경구투여 용량증가 독성시험이철화, 박양춘, 김승형, 진미림, 양원경, 정인철pp. 8-15길경탕의 치밀결합 강화 및 MMPs의 활성 억제를 통한 인체방광암세포의 이동성 및 침윤성의 억제최영현, 홍수현pp. 16-25위암 치료에 대한 한의 임상 가이드라인유화승, 김효영, 김효린, 하예진, 장철용, 백동기, 문구pp. 26-46한국인 기관지 천식 虛證, 實證 환자와 EDN1 유전자 다형성과의 상관성 연구김진주, 정주호, 정승기, 김관일, 백현정, 염유림, 정희재, 김수강, 이범준, 김미아pp. 47-64
원문 보기